Trial Profile
Comparative effects of immediate and extended release formulations of Ciprofloxacin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2017
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Acute sinusitis; Anthrax; Gonorrhoea; Intestinal infections; Intra-abdominal infections; Nosocomial pneumonia; Respiratory tract infections; Skin and soft tissue infections; Typhoid; Urinary tract infections
- Focus Pharmacokinetics; Therapeutic Use
- 28 Jun 2017 New trial record
- 05 Jun 2017 Results presented at the ASM Microbe 2017